chr2-127640153-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001161403.3(LIMS2):c.803-8C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0174 in 1,613,234 control chromosomes in the GnomAD database, including 302 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001161403.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIMS2 | NM_001161403.3 | c.803-8C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000355119.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIMS2 | ENST00000355119.9 | c.803-8C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001161403.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0140 AC: 2132AN: 152230Hom.: 23 Cov.: 33
GnomAD3 exomes AF: 0.0141 AC: 3535AN: 250628Hom.: 52 AF XY: 0.0138 AC XY: 1873AN XY: 135750
GnomAD4 exome AF: 0.0177 AC: 25925AN: 1460886Hom.: 279 Cov.: 32 AF XY: 0.0177 AC XY: 12849AN XY: 726748
GnomAD4 genome AF: 0.0140 AC: 2133AN: 152348Hom.: 23 Cov.: 33 AF XY: 0.0133 AC XY: 989AN XY: 74494
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2W Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at